Evosep at Hupo 2023
We were thrilled to be back at the annual Human Proteomics Conference in Busan, South Korea, meeting with our colleagues, users and friends in the proteomics community. This year, we hosted an Evosep User Appreciation Event and a Breakfast Seminar. See the scientific presence below, and register to our single cell webinar.
New data and research
Get an overview of our new posters presented at HUPO 2023.
poster
Pushing the boundaries for robust and high-throughput single cell
analysis with Whisper Flow technology powered by dia-PASEF
poster
A complete and automated end-to-end sample preparation strategy for high-throughput and standardized proteomics with high sensitivity
poster
Standardized and fully automated deep plasma profiling of plasma integrated with Evosep One enables large scale clinical cohort analysis
Single Cell proteomics
Available on demand
Join us as we uncover how Evosep One empowers researchers to investigate the proteomic landscapes within single cells, paving the way for new discoveries and innovative therapeutic approaches.
Abstracts
This year you can explore new research featuring the Evosep One at HUPO 2023.
Below you can find a complete list of all the submitted abstracts.
Title | Summary |
---|---|
663 – Quantifying 1000 protein groups per minute of microflow LC gradient using data-independent acquisition (DIA) | Neo, Mr. Jason, SCIEX |
220 – Operating, maintaining, and troubleshooting the sensitivity and robustness of timsTOF platforms for proteomics studies | Blatnik, Dr. Renata, Bruker Daltonics GmbH |
232 – Operating, maintaining, and troubleshooting the sensitivity and robustness of timsTOF platforms for proteomics studies | Fatou, Dr. Benoit, Bruker Scientific LLC |
801 – A complete and automated end-to-end sample preparation strategy for highthroughput and standardized proteomics with high sensitivity | Bekker-Jensen, Mrs Dorte, Evosep Biosystems |
124 – Exploring the potential of transplanted colon organoids to mimic human physiology in mice using Deep Visual Proteomics | Post, Mr. Frederik, University of Copenhagen |
633 – Single-cell Proteomics Methodologies on the Orbitrap Tribird Platform for Increased Throughput and Extended Coverage | Lee, Dr. Amanda, Thermo Fisher Scientific |
249 – Novel Developments in Single-Cell Proteomics: Clustering Analysis of Human PBMCs and High-Throughput LC-MS/MS Platform | Li, Dr. Ziyi, Shanghai Applied Protein Technology Co., Ltd. |
834 – Pushing the boundaries for robust and high-throughput single cell analysis with Whisper Flow technology powered by dia-PASEF | Bekker-Jensen, Mrs Dorte, Evosep Biosystems |
825 – Precision Proteomic Landscape of health-to-disease transitions of Rheumatic Musculoskeletal disorders and links to Cancer associate irAEs | Stensballe, Assoc. Prof. Allan, Aalborg University |
503 – High-throughput (phospho)proteomics drug screening in triple-negative breast cancer cell lines uncovers targetable nodes for rational drug combination therapies | Emdal, Asst. Prof. Kristina Bennet, University Of Copenhagen |
486 – Automated sample preparation for human plasma proteomics by SP3 | Sielaff, Mr. Malte, University Medical Center Mainz |
592 – Multiplexed deep plasma profiling using a novel high-resolution accurate mass spectrometer | Albrecht, Mr. Vincent, Max Planck Institute of Biochemistry |
774 – Standardized and fully automated profiling of plasma and extracellular vesicles integrated with Evosep One enables large scale clinical cohort analysis | Vej-Nielsen, Dr. Joel, Evosep Biosystems |
786 – Investigating the plasma proteome of people living with HIV (PLHIV) with ARVassociated acute kidney injury in a South African cohort | Mokoena, Miss Rethabile, CSIR/University Of The Witwatersrand |
418 – Comparative Study of LC-MRM Platforms for the Quantification of Core- Fucosylated AFP Glycopeptides in the Diagnosis of Hepatocellular Carcinoma (HCC) | Suh, Mr. Hanseul, Seegene Medical Foundation |
472 – Optimization of LC-MRM Method for the Quantification of Core-Fucosylated AFP Glycopeptide Using Evosep One and Triple Quad 6500+ system | Park, Ms. Juri, Seegenemedical |
258 – Mass spectrometry-based profiling of small FFPE tissue areas | Fraefel, Mr. Marius, Technical University of Munich |
543 – Exploring sample preparation methods for plasma proteomics | Vendrell, Dr. Iolanda Centre of Translational Proteomics Discovery Proteomics/Cellular Proteomics; TDI-NDMRB, University of Oxford |
579 – Pushing DIA proteomics analyses of neat plasma to 1000 protein groups ID/h | Schmit, Mr. Pierre-Olivier, Bruker France |
652 – Multi-omics profiling of metastatic spread in a large breast cancer patient cohort | Mosquim Junior, Mr. Sergio Department Of Immunotechnology, Lund University, Lund, Sweden |
145 – Integrating Multiplex Staining and Multiplex-DIA: Profiling the Tumor Microenvironment Proteome for Precision Cancer Research | Zheng, Dr. Xiang University Of Copenhagen, Novo Nordisk Foundation Center For Protein Research |
MEET THE TEAM
This year you can meet both representatives from our Applications-, Management-, Sales- and Product team. Learn a little bit about the team at HUPO here.
Nicolai Bache
Head of Applications
Dorte Bekker-Jensen
Senior Scientist
Joel Vej-Nielsen
Scientist
Michael BarRett Andersen
Head of Product Management
Erik Verschuuren
Head of Global Sales
News
(May 2023) Evosep Launches End-to-End Proteomics Workflow, Setting a new Standard for Automated Sample Preparation
At ASMS 2023 Evosep, a leading provider of innovative solutions for proteomics research, proudly announces the release of End-to-End Proteomics Workflow.
(May 2023) EVOSEP AND CELLENION ENTER CO-MARKETING AGREEMENT TO BOOST SINGLE CELL PROTEOMICS
Singapore – AOHUPO (May 9th, 2023). Evosep is pleased to announce a new co-marketing partnership with Cellenion. This partnership will enable researchers to access a complete solution for single-cell proteomics, combining Evosep’s cutting-edge liquid chromatography technology with Cellenion’s advanced single-cell isolation and sample preparation platform.
(March 2023) Evosep and Resyn Biosciences partner to integrate their technologies into new clinical proteomics solutions
ReSyn Biosciences and Evosep have recently demonstrated several joint solutions thatintegrate automated sample purification with liquid chromatography coupled mass spectrometry.
LET’S GET IN TOUCH
We are always open to answering questions and form new collaborations, so don’t hesitate to reach out. Fill out our contact form and we’ll do our very best to assist you.